Vir Biotechnology Inc (VIR)
7.385
+0.04
(+0.61%)
USD |
NASDAQ |
Dec 24, 13:00
7.385
0.00 (0.00%)
After-Hours: 13:26
Vir Biotechnology Free Cash Flow: -473.07M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Janux Therapeutics Inc | -37.82M |
| Biomarin Pharmaceutical Inc | 300.88M |
| Arbutus Biopharma Corp | -71.92M |
| GlycoMimetics Inc | -35.02M |
| FibroGen Inc | -126.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -171.48M |
| Cash from Investing (Quarterly) | 118.60M |
| Cash from Financing (Quarterly) | 0.031M |
| Free Cash Flow Per Share (Quarterly) | -1.272 |
| Free Cash Flow to Equity (Quarterly) | -173.84M |
| Free Cash Flow to Firm (Quarterly) | -173.84M |
| Free Cash Flow Yield | -47.21% |